.jpg)
.jpg)
If this isn’t friendly to your device, details are below:
Workshops
Monday (W3) 16:45-17:45
Navigating the waters of economic evaluations of medical devices
Praveen Thokala
Tuesday (W7) 08:45-09:45
Statistical challenges in HTA
Nick Latimer
Tuesday (W8) 08:45-09:45
The economic evaluation of diagnostics: challenges and methods for assessing value
Ron Akehurst
Tuesday (W11) 08:45-09:45
Multiple challenges in capturing utilities for paediatric conditions
John Brazier
Wednesday (W24) 13:34-14:45
Methods for dealing with treatment switching in clinical trials
Nick Latimer
Wednesday (W25) 13:45-14:45
Navigating the pitfalls around progression-free survival estimation
John Stevens
Issues panels
Tuesday (IP7) 13:45 - 14:45
Making value-based pricing a reality
John Brazier (panelist)
Tuesday (IP8) 13:45-14:45
How are the results from HTA methodology research implemented in the updates of HTA guidelines?
Allan Wailoo (panelist)
Wednesday (IP17) 10:00 - 11:00
How can health economic modellers win the trust of decision makers?
Paul Tappenden (panelist)
Research Podiums
Monday (M01) 14:15-15:15
A guide to adjusting survival time estimates to account for treatment switching in randomised controlled trials
Nick Latimer
Monday (PP2) 14:15-15:15
Multinational consistency of a discrete choice model in quantifying health states for the extended 5-level EQ-5D
Ben van Hout
Monday (CL3) 15:30-16:30
Validation of surrogate endpoints in advanced solid tumours: systematic review of statistical methods, results and implications for policy makers.
Paul Tappenden
Posters
Monday (PRS6) Discussion: 13:15-14:15
Systematic review of colistimethate sodium dry powder and tobramycin dry powder antibiotics for pseudomonas aeruginosa lung infection in cystic fibrosis
Sue Harnan
Monday (PRS38) Discussion: 13:15-14:15
The cost-effectiveness of dry powder antibiotics for the treatment of pseudomonas aeruginosa in patients with cystic fibrosis
Paul Tappenden
Monday (PCN89) Discussion: 18:30-19:30
Economic evaluation of an electrical impedance spectoscopy (EIS) device used as an adjunct to colposcopy
Alice Bessey
Monday (PCN97) Discussion: 18:30-19:30
A systematic review and critical appraisal of economic evaluations of radiotherapy for cancer
Roberta Ara
Monday (PCN107) Discussion: 18:30-19:30
Economic evidence of surgical procedures in cancer:
a systematic literature review
Hasan Basarir
Monday (PCN121) Discussion: 18:30-19:30
Evaluating the cost effectiveness of gene expression profiling and immunohistochemistry tests
Rachid Rafia
Tuesday (PHP216) Discussion: 12:45-13:45
Comparing the value of different HTA decision making process: evaluating the evaluators
Allan Wailoo
Tuesday (PCV90) Discussion: 18:00-19:00
Issues with cost-effectiveness modelling of diagnostic tests – case study of ischaemic cardiomyopathy
Praveen Thokala
Tuesday (PCV105) Discussion: 18:00-19:00
Telemonitoring after discharge from hospital with heart failure – cost-effectiveness modelling of alternative service designs
Praveen Thokala
Tuesday (PMS61) Discussion: 18:00-19:00
Health economic modelling of sequential therapies for rheumatoid arthritis: A systematic review
Jon Tosh
Wednesday (PRM32) Discussion: 12:45-13:45
Development of the ScHARR Health Utilities Database (HUD)
Angie Rees
Wednesday (PRM178) Discussion: 12:45-13:45
Modelling the relationship between the Womac osteoarthritis index and EQ-5D
Allan Wailoo
Wednesday (PRM230) Discussion: 12:45-13:45
Should there be an option to “unrefer” NICE single technology appraisals: case study of aripiprazole for bipolar I disorder in adolescents
Lesley Uttley